Special Issues
Editorial Board
Editors-in-Chief
  • Edward Chu

    Albert Einstein College of Medicine, USA

    Interests: cancer pharmacology and drug development

  • Enrico Mini

    University of Florence Florence, ITALY

    Interests: the mechanisms of tumor drug resistance, in particular to antimetabolites and metal-based drugs, cancer pharmacogenomics and pharmacogenetics, and controlled clinical trials in gastrointestinal cancers

  • Hailin Tang

    Sun Yat-sen University Cancer Center, CHINA

    Interests: The molecular mechanism of tumorigenesis and metastasis

Editorial Board Members
  • Sirin A. Adham

    Department of Biology, College of Science, Sultan Qaboos University, Muscat, OMAN

    Interests: breast cancer, integrin beta 3, chemoresistance, adriamycin, cyclophosphamide

  • Aamir Ahmad

    University of Alabama at Birmingham, USA

    Interests: cancer metastasis, drug resistance, miRNA and cancer health disparity

  • Mamoun Ahram

    The University of Jordan, JORDAN

    Interests: cancer biology, molecular and cell biology, biobanking, breast cancer, androgen

  • Dante Amelio

    Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari (APSS), ITALY

    Interests: astrocytoma, bone tumor, brain tumor, chordoma, craniopharyngioma, glioblastoma, meningioma, pituitary tumor, schwannoma

  • Roberto Bei

    Facoltà di Medicina e Chirurgia Università degli Studi di Roma Tor Vergata Rome, ITALY

    Interests: Oncology: Analysis of immune response to tumor associated antigens (ErbB receptors, AFP, CEA, PSA) in cancer patients and cancer immunotherapy. Analysis of the expression of tumor antigens in tumors and normal tissues; Virology: Production and characterization of monoclonal antibodies to viral proteins; Nutrition: Effect of natural compounds on cancer cell growth.

  • Luca Bertolaccini

    European Institute of Oncology IRCCS, ITALY

    Interests: lung cancer surgery, minimally invasive thoracic surgery, thoracic oncology, biostatistics

  • Guido Bocci

    University of Pisa, ITALY

    Interests: Cancer Biology; Clinical Studies; Pharmacodynamics; Clinical Pharmacokinetics; Pharmacokinetics; Genetics Oncology; Tumors; Cancer Research

  • Giuseppe Broggi

    Department “G.F. Ingrassia”, Anatomic Pathology, University of Catania, ITALY

    Interests: Molecular Biology, Cancer Research, Neuropathology and Histopathology

  • George Gong CHEN

    The Chinese University of Hong Kong, HONG KONG

    Interests: head and neck cancers, especially thyroid cancer and laryngeal cancer

  • William CHO

    Queen Elizabeth Hospital, HONG KONG

    Interests: molecular biology, proteomics, genomics, immunology, bioinformatics, next-generation sequencing

  • Maria Caffo

    University of Messina, ITALY

    Interests: glioblastoma multiforme (GBM), astrocytoma, medulloblastoma, neuroradiology, magnetic resonance, glioma, molecular oncology, meningioma,neurosurgery

  • Jianyuan Chai

    Inner Mongolia University of Science and Technology, CHINA

    Interests: molecular and cellular biology of wound healing, angiogenesis, apoptosis, cancer development, esophageal cancer, gastrointestinal injury and malignancy

  • Nipon Chattipakorn

    Cardiac Electrophysiology Research and Training Center (CERT), Thailand; Faculty of Medicine, Chiang Mai University, THAILAND

    Interests: Cardio-oncology, chemotherapy-induced cardiotoxicity, mitochondria, programmed cell death, molecular cardiology

  • Xiaofang Che

    The First Hospital of China Medical University, CHINA

    Interests: tumor microenvironment, hypoxia, immunology, cancer, proliferation, drug resistance, metastasis, exosome, non-cording RNA, m6A methylation, post-translational modification, biomarker

  • Tianhui Chen

    Zhejiang Cancer Hospital, CHINA

    Interests: clinical epidemiology, molecular epidemiology, genetic epidemiology of familial cancer (colorectal cancer, breast cancer, ovarian cancer, pancreatic cancer)

  • Maoquan Chu

    Tongji University, CHINA

    Interests: advanced nanostructures for in vivo target drug delivery, advanced nanostructures and strategy for in vivo cancer target imaging and therapy

  • Ri Cui

    School of Pharmaceutical Sciences Wenzhou Medical University, CHINA

    Interests: Bioinformatics, Cancer Research, Cell Biology, non-coding RNAs, cancer pathogenesis

  • Valentina De Falco

    Consiglio Nazionale delle Ricerche, ITALY

    Interests: Molecular Oncology, Preclinical Investigation, Targeted Therapies, Kinase Inhibitors, Personalized Medicine

  • Vittorio Gebbia

    University of Enna Kore, ITALY

    Interests: medial oncology, hematology, lung cancer, chemotherapy

  • David A. Gewirtz

    Virginia Commonwealth University, USA

    Interests: autophagy, cell biology, programmed cell death, apoptosis and senescence

  • Bahil Ghanim

    Karl Landsteiner University of Health Sciences, AUSTRIA

    Interests: biomarkers, thoracic surgery, lung cancer, mesothelioma, minimal invasive surgery and solitary fibrous tumor of the lung

  • Pia Giovannelli

    University of Campania “L. Vanvitelli”, ITALY

    Interests: cancer biology, molecular biology, cancer cells, epigenetics, gene expression

  • Nocentini Giuseppe

    University of Perugia, ITALY

    Interests: pharmacology, immunotoxicology and pharmacoimmunology

  • Manuel Graeber

    The University of Sydney, AUSTRALIA

    Interests: brain tumours, glioblastoma, microglia, brain macrophages, tumour microenvironment, neurogenetics

  • Zongsheng Guo

    Roswell Park Comprehensive Cancer Center, UNITED STATES

    Interests: Cancer Immunotherapy, Oncolytic Viruses, Epigenetic Therapy, and Cancer Biology

  • Sanjay Gupta

    Case Western Reserve University, USA

    Interests: cancer biomarkers, cancer therapeutics and drug repurposing and cancer stem cells research

  • Jing He

    Guangzhou Women and Children's Medical Center, CHINA

    Interests: cancer genetics, cancer epidemiology, molecular epidemiology, cancer therapy, signal transduction, pediatric oncology, evidence-based medicine (meta-analysis), molecular biology

  • Mehdi Hedayati

    Shahid Beheshti University of Medical Sciences, Research Institute for Endocrine Science, Cellular and Molecular Endocrine Research Center, IRAN

    Interests: biochemistry and genetic aspects of thyroid cancer, biostatistics, endocrine oncology

  • Ryouichi Horie

    Kitasato University, JAPAN

    Interests: molecular hematology, medical sciences

  • Ciro Isidoro

    Università del Piemonte Orientale, ITALY

    Interests: cancer biology, autophagy, cell death, cell biology, cancer research, apoptosis, cell proliferation

  • Gyeong-Hoon Kang

    Department of Pathology, Seoul National University College of Medicine, Seoul, Korea; Laboratory of Epigenetics, Seoul National University Cancer Research Institute, Seoul, KOREA

    Interests: Lower gastrointestinal tract pathology, DNA methylation, Epigenetics, Gastrointestinal cancer

  • Naoki Katase

    Department of Oral Pathology, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, JAPAN

    Interests: Head and neck squamous cell carcinoma (HNSCC); oral cancer; gene therapy

  • Snježana Kaštelan

    School of Medicine, University of Zagreb, CROATIA

    Interests: etiopathogenesis of diabetic retinopathy, glaucoma, and ocular oncology

  • Shirabe Ken

    Graduate School of Medical Sciences Fukuoka, JAPAN

    Interests: Hepato-pancreato-biliary Surgery, Liver Transplantation Surgery

  • Cheorl-Ho Kim

    Sungkyunkwan University, KOREA

    Interests: innate immunity; microbe-host interasction; angiogensis; differentiation; invasion; ethnopharmcology; molecular and cellular glycobiology; cancer research

  • I-Ta Lee

    School of Dentistry, Taipei Medical University, Taipei, Taiwan

    Interests: Oral Pathology; Oral Medicine; Inflammatory Biomarkers; Cell Signaling; Inflammatory diseases; Cancers; Anticancer effects and mechanisms of Chinese herbal medicine

  • Chien-Feng Li

    Chi Mei Medical Center, TAIWAN

    Interests: the effect of genetic, epigenetic, expression, and metabolic alternations on cancer progression and metastasis

  • Yingying Lin

    Shanghai Jiaotong University, CHINA

    Interests: tumor microenvironment, protease, glioma

  • Tao Liu

    Lowy Cancer Research Centre, AUSTRALIA

    Interests: oncology and carcinogenesis, cancer cell biology, cancer genetics, cancer therapy

  • Jinhui Liu

    The First Affiliated Hospital of Nanjing Medical University, CHINA

    Interests: biomarker, prognostic model, non-coding RNA, machine learning, bioinformatics, immunology

  • Ying Liu

    Qingdao University, CHINA

    Interests: basic and applied research on nuclear receptor signal transduction, protein post-translational modification, identification of tumor biomarkers, and bioinformatics

  • Cesar Lopez-Camarillo

    Universidad Autónoma de la Ciudad de México Mexico, MEXICO

    Interests: microRNAs, lncRNAs and proteins deregulated in cancer using diverse omics approaches (genomics, proteomics, expression profiling, etc).

  • Wenxue Ma

    University of California, USA

    Interests: cancer stem cell (CSC), cancer immunotherapy, antigen presentation, tumor neoantigens, Cytotoxic T-Lymphocytes (CTLs), tumor-infiltrating lymphocytes (TILs), dug delivery with nanotechnology (Nanomedicine), targeted cancer therapy, circulating tumor cell (CTC), biomarkers

  • Muzafar Ahmad Macha

    Watson-Crick Center for Molecular Medicine, Islamic University of Science and Technology (IUST), Awantipora, Kashmir, INDIA

    Interests: Genetic/Epigenetic modification in cancer, Signal transduction mechanisms, Novel therapeutics for the treatment of Head and Neck Squamous cell carcinoma (HNSCC), Esophageal and Pancreatic Cancer, Development of Genetically Engineered Mouse models of HNSCC, Artificial Intelligence and Cancer

  • Chun Mao

    School of Chemistry and Materials Science, Nanjing Normal University, Nanjing, CHINA

    Interests: Nanobiotechnology; Nanomaterials; Bionanotechnology; Tumor Therapy

  • Sebastiano Mercadante

    La Maddalena Cancer Center, ITALY

    Interests: cancer pain, palliative medicine, anesthesiology

  • Constantinos Mikelis

    University of Patras, GREECE

    Interests: investigating the role of the small GTPase RhoA on developmental and tumor-induced angiogenesis, lymphangiogenesis, on the role of endothelial RhoA on cancer cell trans-endothelial migration, signaling circuits, genetic alterations taking place in the endothelium upon incorporation of cancer-derived exosomes, as part of the pre-metastatic niche

  • Hiroshi Miyamoto

    Director of Genitourinary Pathology at University of Rochester Medical Center, Professor of Pathology & Laboratory Medicine and Urology, University of Rochester School of Medicine and Dentistry, Rochester, USA

    Interests: Bladder and prostate cancers; molecular biology of steroid hormone receptors in genitourinary tumors; the role of androgen receptor signaling in promoting the development and progression of bladder cancer, as well as resistance to non-surgical therapy

  • Giovanni Monteleone

    University of Rome Tor Vergata, ITALY

    Interests: gastroenterology, cancer immunity and immunotherapy, liver and clinical research

  • Yuseok Moon

    Pusan National University, KOREA

    Interests: Microbiology, Cell Biology, Molecular Biology, Toxicology, Immunology

  • Yasser Fakhri Mustafa

    Department of Pharmaceutical Chemistry, University of Mosul, Mosul, Iraq

    Interests: drug design, pharmaceutical chemistry, cancer therapy

  • Jiri Neuzil

    Griffith University, Brisbane, AUSTRALIA

    Interests: Cancer Research, Molecular Biology, Cell Biology

  • Kiyoshi Ohtani

    Department of Biomedical Sciences, School of Biological and Environmental Sciences, Kwansei Gakuin University, 1 Gakuen Uegahara, Sanda, Hyogo 669-1330, JAPAN

    Interests: Cell Growth Control, Cancer Research

  • Hiroyuki Osada

    RIKEN Center for Sustainable Resource Science (CSRS), JAPAN

    Interests: chemical biology research

  • Chunlin Ou

    Xiangya Hospital, Central South University, CHINA

    Interests: the regulatory mechanism of non-coding RNAs in cancers, clinical application of mRNA vaccine in cancers.

  • Wen-Bin Ou

    Zhejiang Sci-Tech University, CHINA

    Interests: functional mechanisms of receptor tyrosine kinases, tumor suppressors, and oncogenes in lung cancer, mesothelioma, sarcomas, and target drug resistant mechanisms

  • Mohammad Oves

    King Abdulaziz University, SAUDI ARABIA

    Interests: multidrug resistance, antimicrobial agents and nanomaterials bio-fabrication, biofilm, chromium reduction and phosphate solubilization microbe

  • Petar Ozretić

    Laboratory for Hereditary Cancer, Ruđer Bošković Institute (RBI), CROATIA

    Interests: cancer genetics, epigenetics, bioinformatics, biostatistics and molecular oncology

  • Pierlorenzo Pallante

    IEOS, Consiglio Nazionale delle Ricerche (CNR), ITALY

    Interests: non-coding RNA, cancer biology, biomarkers, cell biology, cancer therapy, prognosis, pharmacology, cancer chemotherapy, translational research in the field of lung and colorectal oncology

  • Roberto Passera

    University of Torino, AOU Città della Salute e della Scienza (Molinette Hospital), ITALY

    Interests: cancer clinical epidemiology and biostatistics, systematic reviews and meta-analyses in surgical oncology, chemo- and immunochemo- regimens in onco-hematology, new biomarkers for prostate cancer, pharmacokinetic and pharmacodynamic trials in oncology

  • Godefridus (Frits) J. Peters

    Department Medical Oncology, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Department of Biochemistry, Medical University of Gdansk, POLAND

    Interests: translation of preclinical pharmacology of anticancer agents to the clinic, regulation of transport, cellular drug distribution, metabolism of anticancer drugs, DNA repair, apoptosis and protein processing

  • Abdur Rauf

    Department of Chemistry, University of Swabi, Swabi, PAKISTAN

    Interests: Medicinal Chemistry; Pharmacology; Nanotechnology; Organic Chemistry; Metabolites; Pharmaceutical Chemistry; Anticancer

  • Leonardo Oliveira Reis

    Pontifical Catholic University of Campinas, BRAZIL

    Interests: prostate cancer; urologic surgical; bladder cancer; cancer diagnostics; urologic oncology; cryosurgery; translational research; evidence based medicine; hydronephrosis

  • Hasan Mahmud Reza

    North South University, BANGLADESH

    Interests: pharmaceutical dosage form development, pharmacological studies with natural products and available molecules using animal disease models, molecular biology and biochemistry, cell culture

  • Belgin SEVER

    Anadolu Üniversitesi, TURKEY

    Interests: targeted anticancer drug development; medicinal chemistry; computational chemistry; QSAR; molecular modelling; molecular simulations; virtual screening; in silico ADME analysis; drug design and development

  • Jan H.M. Schellens

    Modra Pharmaceuticals B.V., Amsterdam, North Holland, NETHERLANDS

    Interests: Medical oncology, Translational and clinical oncology research, Clinical pharmacology, Pharmacology, General internal medicine, Regulatory strategies, Health Technology Assessment, Project management, Innovation management

  • Consolato Sergi

    University of Ottawa, CANADA

    Interests: biology and pathology of the cardiovascular, gastrointestinal System and gut, bile microbiome, bone cell biology, pediatric pathology with nanotech applications for oncology

  • Zhendong Shi

    Tianjin Medical University Cancer Institute and Hospital,CHINA

    Interests: Clinical Immunology, Oncology, Nanomedicine, Breast cancer

  • Alexander Shtil

    Blokhin Cancer Center, Moscow, RUSSIA

    Interests: mechanisms of tumor cell death, drug resistance, antitumor drug design

  • Yang Shun-Fa

    Chung Shan Medical University, Taichung, TAIWAN

    Interests: pharmacology, oral cancer metastasis, cancer biology, genetic polymorphism and environment risk factors in oral cancer

  • Johnson Stanslas

    Pharmacotherapeutics Unit, Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, MALAYSIA

    Interests: Clinical Pharmacology, Cancer Research, Neuroscience, Oncology, Pharmacy

  • Stefania Nobili

    University of Florence, ITALY

    Interests: pharmacology, applied pharmacology

  • Yong Teng

    Emory University School of Medicine, USA

    Interests: tumor microenvironment, tumor metabolism, and metastasis with an emphasis on molecular determinants

  • Giovanni Tossetta

    Dept Expt & Clin Med, Università Politecnica delle Marche, Ancona, ITALY

    Interests: Endometriosis, Endometrial cancers, Ovarian Cancer, Immunofluorescence Staining, Colon Cancer, Signalling, Western Blot, Cytokines, Immunohistochemistry, ELISA, Cell Culture, Real-Time PCR

  • Chin-Hsiao Tseng

    National Taiwan University Hospital, TAIWAN

    Interests: diabetes, arsenic-related health hazards, cancer issues related to diabetes and antidiabetic drugs

  • Jinhua Wang

    National Center for Pharmaceutical Screening, Institute of Materia Medica, CHINA

    Interests: the mechanism and drug targets of cancers

  • Jaw-Yuan Wang

    Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Chong-Ho Memorial Hospital, TAIWAN

    Interests: Surgical and Molecular oncology, Colorectal cancer, Gastrointestinal malignancy and disease, Nutrition therapy, Robotic surgery, Microbiota

  • Paul Workman

    The Institute of Cancer Research, London, UK

    Interests: Cancer biology, Drug development, Drug discovery, Pre-clinical research, Personalised molecular medicine, Cancer genome

  • Guoxiong Xu

    Research Center for Clinical Medicine, Jinshan Hospital, Fudan University, CHINA

    Interests: Oncology, Physiology, Cell Biology, Molecular Biology, Apoptosis, Cell Signaling, Cancer Biology, Cell Proliferation, Cancer Biomarkers

  • Young Yang

    Sookmyung Women's University Seoul, SOUTH KOREA

    Interests: Tumor EMT&MET; Mesenchymal Stem cells and Immune regulation; Bone Homeostatsis; Metabolic rewiring

  • Hooman Yarmohammadi

    Memorial Sloan-Kettering Cancer Center, USA

    Interests: diagnostic radiology; diagnosis; pancreatic cancer; interventional radiology; endovascular procedures; tumors; lung; cancer biology; animal studies

  • Zhiling Yu

    Hong Kong Baptist University Hong Kong, HONG KONG

    Interests: Melanoma; Atopic dermatitis; Cancer; Skin care; Pharmacology; Inflammation

  • Xu Dong Zhang

    University of Newcastle, AUSTRALIA

    Interests: melanoma, pancreatic, colorectal & rare cancers

Early Career Editorial Board Member
  • Jiyoon Bu

    INHA University, KOREA

    Interests: drug delivery, nano engineering, liquid biopsy, immunotherapy

  • Meran Keshawa Ediriweera

    University of Colombo, SRI LANKA

    Interests: biochemistry, cancer, cancer epigenetics, pharmacognosy, ethnopharmacology

  • Abu Hazafa

    University of Salerno, ITALY

    Interests: CAR-T cells, tumor immunotherapy, cancer biology, natural product drug discovery

  • Chen Li

    Free University of Berlin, GERMANY

    Interests: cancer metabolism; cancer immunotherapy; adipose tissue; diabetes non-alcoholic fatty liver disease

  • Fernando Mendes

    Instituto Politécnico de Coimbra, PORTUGAL

    Interests: lung cancer, lymphoma, blood bank, immunhematology, cancer treatement, radiotherapy, immune system, forsman blood group

  • Jialin Meng

    The First Affiliated Hospital of Anhui Medical University, CHINA

    Interests: clinical and basic research on prostate diseases, chronic prostatitis and prostate cancer

  • Jafar Rezaie

    Solid Tumor Research Center, Urmia university of Medical Sciences, Urmia, IRAN

    Interests: Extracellular Vesicles(EVs) biology; Exosome signaling pathway; Diagnosis and treatment of cancer; Developmental biology; Immunology

  • Mohsen Sheykhhasan

    Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, IRAN

    Interests: Hematology; Microbiology Cell; Biology; Biotechnology; Orthopedic Surgery; T-cell immunotherapy; Cell biology; Targeted cancer therapy; Biomarkers; Exosomes; Viral infection; Pathophysiology of peripheral vascular and neurological diseases; Crosstalk between long non-coding RNAs and gene signaling pathways

  • Le Su

    Jacksonville State University, USA

    Interests: epigenetics, childhood cancer (molecular and cellular basis of childhood sarcomas), targeted therapy

  • Yapeng Su

    Program in Immunology & Herbold Computational Biology Program, Fred Hutchinson Cancer Center, UNITED STATES

    Interests: cancer metabolism; cell biology; T cell therapy; systems biology; immunology; cancer

  • Yaying Sun

    Huashan Hospital, CHINA

    Interests: multi-organic crosstalk in terms of musculoskeletal and immune system, development of novel nanomedicine delivery system, prognostic factors and predictive model establishment of different cancers

  • Ziheng Wang

    Nantong University, CHINA

    Interests: bioinformatics analysis; clinical problems with machine learning; oncology using single-cell omics strategies; basic and clinical research studies; molecular pathology; etiology and pathogenesis; biomarkers; genomics; transcriptome; proteomics; metabonomics; prognosis

  • Hao Zhang

    Chongqing Medical University, CHINA

    Interests: tumor microenvironment; cancer immunotherapy; small molecule drug; molecular mechanism; bioinformatics; target therapy; signal transduction

  • Zhongbao Zhou

    Urology Surgery, Beijing Tian Tan Hospital, Capital Medical University, CHINA

    Interests: Renal Cell Carcinoma; Bladder Cancer; Prostatic Cancer

  • Yutian Zou

    Sun Yat-sen University Cancer Center, CHINA

    Interests: Breast cancer; Immunotherapy; Tumor microenvironment; Anti-HER2 therapy; Drug resistance; Single-cell sequencing; CRISPR; CircRNA; Cell death; Ferroptosis; Organoid; Bioinformatics

Editorial Advisory Board
  • L. J. Appleman

    University of Pittsburgh, USA

    Interests: tumor immunology, clinical trial of an autologous dendritic cell vaccine, cancer immunotherapy

  • N. Bahary

    University of Pittsburgh, USA

    Interests: oncologists diagnose, cancer surgeons, or surgical oncologists, remove tumors, while medical oncologists treat cancers with chemotherapy, gastrointestinal cancer

  • M. S. Copur

    University of Nebraska, USA

    Interests: medical oncology, hematology

  • S. Gantsev

    Bashkirian State Medical University, RUSSIAN

    Interests: pharmacology

  • Y. Horiguchi

    Tokyo Medical University, JAPAN

    Interests: biomaterials and bioengineering

  • M. Imoto

    Keio University, JAPAN

    Interests: nanotechnology, materials, chemical biology

  • H. Kakeya

    Kyoto University, JAPAN

    Interests: chemical biology

  • M. Kawatani

    RIKEN, JAPAN

    Interests: interdisciplinary science & engineering, biological sciences

  • Y. Li

    Sorrento Therapeutics, USA

    Interests: tumor immunology, molecular biology, medical genetics and clinical medicine

  • O. Ohno

    Kogakuin University, JAPAN

    Interests: immunology

  • M. Oya

    Keio University, JAPAN

    Interests: urology

  • A. Di Paolo

    University of Pisa, ITALY

    Interests: pharmacology, clinical pharmacokinetics and PK/PD of antineoplastic and antiinfective drugs

  • J. Robert

    Université de Bordeaux, FRANCE

    Interests: pharmacocinétique, métabolisme et résistance, pharmacologie cellulaire et moléculaire, pharmacogénétique

  • J. C. Schmitz

    University of Pittsburgh, USA

    Interests: pharmacodynamic, the mechanism(s) of action of quassinoids on colorectal cancer cells and tumors

  • K. Sidthipong

    Mahidol University, THAILAND

    Interests: biology, chemistry, bioorganic & medicinal chemistry letters

  • S. Simizu

    Keio University, JAPAN

    Interests: cancer, molecular target therapy, inflammation, chemical biology

  • E. Tashiro

    Showa Pharmaceutical University, JAPAN

    Interests: nature chemical biology

  • L. Zhang

    University of Pittsburgh, USA

    Interests: pharmacology and chemical Biology

Emeritus Editor-in-Chief
  • Late Prof. Kazuo Umezawa

    Aichi Medical University, JAPAN

    Interests: CPR, resuscitation, critical care medicine, intensive care medicine, hypothermia, emergency management, emergency treatment, sepsis, ventilation, ICU

Share Link